Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 45
  • Start Date: September 3, 2019
Effect of Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 185
  • Start Date: August 6, 2019
A Randomized, Double-Blind, Placebo-Controlled Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: January 1, 2019
Effect of Varenicline on Smoking Cessation in Patients With Schizophrenia: Evaluation of Antipsychotic Drug-Induced Neurological Symptoms as Correlates of Response
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement
  • Participants: 50
  • Start Date: December 1, 2017
Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 10
  • Start Date: May 2015
A Feasibility Clinical Trial of the Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for the Management of Treatment-Refractory Movement Disorders
Showing 1-5 of 5